Although SA-Ts are involved in the pathogenesis of metabolic disorders [15] and the autoimmune disease systemic lupus erythematosus [16], Yoshida et al. recently reported that the elimination of SA-T cells using a CD153 vaccine improved glucose tolerance and insulin sensitivity [44]. This evidence concerns the gene TNFSF8 and metabolic disease.